Results 211 to 220 of about 189,065 (308)

Detection of CXCL10 chemokine level in serum of patients with warts

Egyptian Journal of Medical Research
Yasser Mostafa Gohary, Hanan Abd Elrazek Kamel, hoda Ryad, Eman Mounir Abd El Gawad   +3 more
openaire   +1 more source

In vitro muscle contraction: A technical review on electrical pulse stimulation in C2C12 cells

Experimental Physiology, EarlyView.
Abstract Electrical pulse stimulation (EPS) of skeletal muscle cells is increasingly used to model exercise In vitro. The murine C2C12 myotube system has become a common platform for such studies, yet wide variability in EPS protocols hampers reproducibility and cross‐study comparisons.
Mark R. C. van de Meene, Anita M. van den Hoek, Roeland Hanemaaijer, Lars Verschuren, Jelle C. B. C. de Jong   +4 more
wiley   +1 more source

Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma. [PDF]

Mol Ther Oncol
Jayne WP, Freilich ME, Solanki R, Challagundla KB.   +3 more
europepmc   +1 more source

Chemokine CXC motif ligand 10 (CXCL10; IP-10) [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

Dendritic cell‐specific hypoxia‐inducible factor‐1α deficiency protects mice from recurrent retroviral infection

Experimental Physiology, EarlyView.
Abstract Antigen‐processing and ‐presenting cells play a pivotal role in initiation of the antiviral immune response. The cellular adaption of dendritic cells to reduced oxygen and nutrition levels at the site of infection is regulated predominantly by the transcription factor complex hypoxia‐inducible factor‐1 (HIF‐1).
Timm Schreiber, Yvonne Hüsecken, Claudia Lodewick, Simone Schimmer, Gennadiy Zelinskyy, Ulf Dittmer, Kathrin Sutter, Joachim Fandrey, Sandra Winning   +8 more
wiley   +1 more source

CCL22-producing macrophages are associated with Th1-related sweat duct inflammation in acquired idiopathic generalized anhidrosis. [PDF]

Front Immunol
Takei S, Hayashi R, Okamura M, Katsumi T, Kawai T, Abe R.   +5 more
europepmc   +1 more source

Resveratrol: Advance on the Most Recent Research From 2021 to 2025

Phytochemicals in Food and Medicine, Volume 1, Issue 3, September 2026.
This review summarizes recent progress in resveratrol research (2021–2025), highlighting its natural sources, bioactivities, clinical evidence, and safety profiles. Resveratrol exerts multi‐target effects through the regulation of oxidative stress, inflammation, mitochondrial function, and gut microbiota.
Quanyong Wu, Boya Ouyang, Yi Yuan, Jesus Simal‐Gandara, Hui Cao   +4 more
wiley   +1 more source

Inflammatory biomarkers associated with infection-related type I acute respiratory failure. [PDF]

World J Emerg Med
Ren K, Xu J, Wang Y, Li Y, Zhu H.
europepmc   +1 more source

Polatuzumab Vedotin Enhances Intratumoral T‐Cell Infiltration and Demonstrates Combinatorial Efficacy With Anti‐CD20/CD3 Bispecific Antibody in a Syngeneic B‐Cell Malignancy Mouse Model

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Introduction Polatuzumab vedotin (Pola) is an anti‐CD79b antibody‐drug conjugate. Clinical evidence supports the combination efficacy of Pola with mosunetuzumab or glofitamab, both anti‐CD20/CD3 bispecific antibodies (anti‐CD20/CD3 BsAbs). However, the influence of Pola on the tumor microenvironment and its impact on the efficacy of anti‐CD20 ...
Mayu Tomita, Sei Shu, Natsumi Kawasaki, Satoko Takagi, Shigeki Yoshiura, Yoriko Yamashita‐Kashima   +5 more
wiley   +1 more source

The Role of Inflammasome in the Pathogenesis of Alopecia Areata: NLRP3 and Its Cascade Contribute to the Onset and Early Stage of Alopecia Areata. [PDF]

Ann Dermatol
Lim JH, Kang DH, Moon H, Kwon SH, Lew BL.   +4 more
europepmc   +1 more source